chr9-95449266-T-G

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000264.5(PTCH1):​c.3607A>C​(p.Ser1203Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000959 in 1,564,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. S1203S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000092 ( 0 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.48

Publications

1 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000264.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11942631).
BP6
Variant 9-95449266-T-G is Benign according to our data. Variant chr9-95449266-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 570982.
BS2
High AC in GnomAdExome4 at 13 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.3607A>Cp.Ser1203Arg
missense
Exon 22 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.3604A>Cp.Ser1202Arg
missense
Exon 22 of 24NP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.3451A>Cp.Ser1151Arg
missense
Exon 21 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.3607A>Cp.Ser1203Arg
missense
Exon 22 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.3604A>Cp.Ser1202Arg
missense
Exon 22 of 24ENSP00000389744.2Q13635-2
PTCH1
ENST00000429896.6
TSL:1
c.3154A>Cp.Ser1052Arg
missense
Exon 22 of 24ENSP00000414823.2Q13635-4

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000921
AC:
13
AN:
1412204
Hom.:
0
Cov.:
31
AF XY:
0.0000143
AC XY:
10
AN XY:
697842
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32476
American (AMR)
AF:
0.00
AC:
0
AN:
36550
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25272
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37212
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49452
Middle Eastern (MID)
AF:
0.000699
AC:
4
AN:
5720
European-Non Finnish (NFE)
AF:
9.21e-7
AC:
1
AN:
1086316
Other (OTH)
AF:
0.000137
AC:
8
AN:
58608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152182
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41458
American (AMR)
AF:
0.0000655
AC:
1
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
-
Gorlin syndrome (1)
-
1
-
Holoprosencephaly 7;C2751544:Basal cell carcinoma, susceptibility to, 1;CN376810:Basal cell nevus syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Uncertain
0.025
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
16
DANN
Benign
0.87
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.38
N
LIST_S2
Uncertain
0.87
D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
2.0
M
PhyloP100
2.5
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.30
N
REVEL
Benign
0.20
Sift
Benign
0.53
T
Sift4G
Benign
0.54
T
Varity_R
0.043
gMVP
0.50
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1564008885;
hg19: chr9-98211548;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.